-
In this case-based module, Murielle Francois, IDE; Maria Lopez-Parra, RN, Master in Bioethics, Master in Education and ICT e-learning; and Josephine Schulz, BSc (Hons), RGN MSc, provide strategies for providing optimal patient care as it relates to patient education and pretreatment counseling; adverse event prevention, identification, and management; and on-treatment patient support during HCV therapy.
-
In this ClinicalThought™ highlights module, Raymond T. Chung, MD, Graham R. Foster, FRCP, PhD, and Mark S. Sulkowski, MD, discuss treatment and management issues for patients with viral hepatitis.
-
This CME/CE-certified activity provides clinical management insights from leading experts on the care of patients with hepatitis C.
-
In this interactive program, Raymond T. Chung, MD, reviews current challenges with HCV therapies, describes novel classes of anti-HCV agents and their anticipated benefits for patients, and walks through a series of cases designed to evaluate the question of treating now vs waiting for future HCV therapies.
-
This interactive video module provides a wealth of practical strategies for overcoming challenges associated with direct-acting antiviral therapies for HCV, including input from real patient experiences and expert guidance from a multidisciplinary expert faculty.
|
Latest Educational Activities
-
In this case-based module, Murielle Francois, IDE; Maria Lopez-Parra, RN, Master in Bioethics, Master in Education and ICT e-learning; and Josephine Schulz, BSc (Hons), RGN MSc, provide strategies for providing optimal patient care as it relates to patient education and pretreatment counseling; adverse event prevention, identification, and management; and on-treatment patient support during HCV therapy.
Faculty: Murielle Francois IDE, Maria Lopez-Parra RN, Master in Bioethics, Master in Education and ICT e-learning, Josephine Schulz BSc(Hons) RGN MSc
Released: 4/19/2013
-
In this ClinicalThought™ highlights module, Raymond T. Chung, MD, Graham R. Foster, FRCP, PhD, and Mark S. Sulkowski, MD, discuss treatment and management issues for patients with viral hepatitis.
Faculty: Raymond T. Chung MD, Graham R. Foster FRCP, PhD, Mark S. Sulkowski MD
Released: 2/26/2013
-
This CME/CE-certified activity provides clinical management insights from leading experts on the care of patients with hepatitis C.
Faculty: Nezam H. Afdhal MD, FRCPI, Donald M. Jensen MD, Paul Y. Kwo MD, Andrew J. Muir MD, MHS, David R. Nelson MD, Fred Poordad MD, Mark S. Sulkowski MD, Stefan Zeuzem MD, Sherilyn C. Brinkley MSN, CRNP
Released: 1/10/2013
-
In this Expert Analysis, Jordan J. Feld, MD, MPH, David R. Nelson, MD, and Stefan Zeuzem, MD, provide an in-depth review of the most important new data on viral hepatitis presented at the 2012 AASLD meeting.
Faculty: Jordan J. Feld MD, MPH, David R. Nelson MD, Stefan Zeuzem MD
Released: 1/9/2013
-
In this series of case vignettes, Jordan J. Feld, MD, MPH; Michael W. Fried, MD; Mark S. Sulkowski, MD; and Stefan Zeuzem, MD, weigh the risks and benefits of treating now vs waiting for future therapies in 9 unique case scenarios.
Faculty: Jordan J. Feld MD, MPH, Michael W. Fried MD, Stefan Zeuzem MD
Released: 1/3/2013
-
In this interactive program, Raymond T. Chung, MD, reviews current challenges with HCV therapies, describes novel classes of anti-HCV agents and their anticipated benefits for patients, and walks through a series of cases designed to evaluate the question of treating now vs waiting for future HCV therapies.
Faculty: Raymond T. Chung MD
Released: 12/12/2012
-
This interactive video module provides a wealth of practical strategies for overcoming challenges associated with direct-acting antiviral therapies for HCV, including input from real patient experiences and expert guidance from a multidisciplinary expert faculty.
Faculty: Sherilyn C. Brinkley MSN, CRNP, Monique Carasso MSN, ANP-C, Amy Nathanson PharmD
Released: 10/22/2012
-
In this CME-certified Interactive Virtual Presentation, David D. Liu, PhD, LAc, OMD, and Tram T. Tran, MD, review data identifying important cultural barriers that limit HBV screening and engagement in care among Asian Americans and describe key strategies for overcoming these barriers and cultivating productive interactions between traditional Chinese medicine providers and the Western medical system.
Faculty: David D. Liu PhD, LAc, OMD, Tram T. Tran MD
Released: 10/9/2012
-
This CME-certified activity provides clinical management insights from leading experts on the care of patients with hepatitis C.
Faculty: Nezam H. Afdhal MD, FRCPI, Donald M. Jensen MD, Paul Y. Kwo MD, Andrew J. Muir MD, MHS, David R. Nelson MD, Paul J. Pockros MD, Mark S. Sulkowski MD, Stefan Zeuzem MD
Released: 10/8/2012
-
Joseph J. Eron, Jr., MD, reviews the latest data and guideline recommendations on the optimal use of antiretroviral therapy in patients with HIV infection.
Faculty: Joseph J. Eron, Jr. MD
Released: 8/29/2012
|
|
|